The blood collection market was valued at approximately USD 10,150 million in 2020, and it is expected to reach USD 14,520 million by 2026, registering a CAGR of nearly 6.2% during the forecast period, 2021-2026.
The outbreak of COVID-19 worldwide is expected to have a positive impact on the market because blood testing involves the testing of various blood samples, which helps in the diagnosis of infectious diseases such as COVID-19. Testing remains a crucial step in controlling the COVID-19 pandemic. As the number of COVID-19 cases is increasing worldwide, governments across the globe are exploring the possibilities of allowing private laboratories to ramp up blood testing.
Moreover, the blood reserves have been depleting due to the outbreak of the virus. Many individuals with weak immune systems who have been infected by COVID-19 and are hospitalized need a blood/plasma transfusion. Many governments are also taking initiatives to help increase blood donation. For instance, in June 2020, the Maharashtra state government in India used social media initiatives to increase the number of blood donations. The move was taken following the shortage of blood in the region. Such programs have been driving the blood collection market growth in many regions globally during the pandemic.
Certain factors that are driving the market growth include the rising demand for early diagnosis of chronic conditions, increasing incidence of trauma and accidents, and a surge in the number of surgical procedures carried out worldwide.
Blood collection has also witnessed a great demand due to an increased number of patients suffering from various ailments related to blood, kidney, metabolic diseases, and neurological disorders. Cancers such as leukemia, lymphoma, myeloma, and myelodysplastic syndromes (MDS) can affect the bone marrow, blood cells, lymph nodes, and other parts of the lymphatic system. It has been observed that apheresis technology has been used to reduce the number of white cells until they can be controlled by other medications. According to the Leukemia and Lymphoma Society (LLS), approximately, for every three minutes, one person in the United States is diagnosed with blood cancer. A combined total of 174,250 people in the United States were diagnosed with leukemia, lymphoma, or myeloma in 2018.
In the United Kingdom, the number of surgical procedures has been on the rise in recent years. For instance, in 2019, there were 70,230 accident and emergency (A&E) cases registered in the United Kingdom compared to 59,396 in 2013. Most of the A&E cases require medical procedures. Such emergency cases and accident injuries lead to surgeries, which increase the demand for blood transfusion and, in turn, blood collection.
Moreover, the growing number of accidents also boosts the market growth. According to the WHO in 2020, every year, 1.35 million people die due to road accidents, and 20-50 million suffer from non-fatal injuries. The increasing number of accidents drives the demand for blood products, thereby boosting the market growth.
The steady increase in the number of patients suffering from these diseases and ailments and the growing number of accidents may boost the blood collection market during the forecast period.
Key Market Trends
Needles and Syringes are Expected to Hold a Significant Market Share
The immediate detection of COVID-19 cases requires the wide availability of diagnostics to control the rapid spread of the virus. A public health emergency was determined, justifying the authorization of emergency use of in vitro diagnostics (IVDs) for the diagnosis of COVID-19, which ultimately drives the blood testing market growth across the world. Hence, the needles and syringes segment is expected to see healthy growth over the forecast period. The use of hypodermic needles and syringes is the most common means of blood sampling. Therefore, blood collection needles and syringes are expected to dominate the market owing to their extensive use all across the globe.
Apart from the pandemic, many other infectious diseases are prevalent, increasing the demand for blood specimen collection for diagnosis, thereby boosting the demand for needles and syringes for blood collection.
Various advancements in the field of medical devices are also fueling the market growth. For example, siliconized needles are currently being used in multiple instances to minimize trauma and minimize the risk of vein cross perforation with a short Bevel. Owing to the fact that a huge number of injuries occur within seconds after an invasive device is removed from the vein, presently, the majority of the marketed needles provide immediate protection at the puncture site. Hence, this segment is expected to retain its dominance in the global market over the forecast period.
North America Dominates the Market and is Expected to do the Same in the Forecast Period
North America holds the largest share of the market studied, which is attributed to the increasing demand for blood collection products. An increase in the number of road accidents and the rising prevalence of chronic diseases are the major factors driving the growth of the market studied. With the COVID-19 impact being the highest in the United States, the region foresees good growth in the market during the forecast period.
According to the latest WHO data published in 2018, road traffic accident deaths in Mexico reached 15,292, or 2.70% of the total deaths. The high burden and number of accidents in this country boost the need for blood collection in the region.
As per the estimates of the American National Red Cross, 2021 updated, approximately 36,000 units of red blood cells are needed every day, and nearly 21 million blood components are transfused each year in the United States.
As per the Diabetes Research Institute Foundation, in 2018, an estimated 1.5 million new cases of diabetes were diagnosed among US adults aged 18 years or older, which accounts for approximately 210,000 children and adolescents younger than age 20 years. The growing number of chronic diseases and lifestyle-related disorders requires blood collection for their diagnosis, and this boosts the market growth in the region.
The blood collection market is highly competitive and consists of a number of major players. Companies like Becton, Dickinson and Company, Cardinal Health, F.L. Medical SRL, Greiner Bio-One International GmbH, Haemonetics Corporation, Henry Schein Inc., McKesson Corporation, Medline Industries Inc., PreQ Systems, and Qiagen, among others, hold substantial shares in the market.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
- 1.1 Study Deliverables
- 1.2 Study Assumptions
- 1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Rising Demand for Early Diagnosis of Chronic Conditions
- 4.2.2 Increasing Incidence of Trauma and Accidents
- 4.2.3 Surge in the Number of Surgical Procedures Carried Out Worldwide
- 4.3 Market Restraints
- 4.3.1 Blood Contaminations and Other Complications
- 4.3.2 Injury Caused During Blood Collection
- 4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value)
- 5.1 By Product
- 5.1.1 Needles and Syringes
- 5.1.2 Tubes (Plasma-separating Tubes, Serum-separating Tubes, etc.)
- 5.1.3 Lancets
- 5.1.4 Blood Bags
- 5.1.5 Other Products
- 5.2 By Application
- 5.2.1 Diagnostics
- 5.2.2 Treatment
- 5.3 By End User
- 5.3.1 Hospitals and Diagnostic Centers
- 5.3.2 Blood Banks
- 5.3.3 Other End Users
- 5.4 Geography
- 5.4.1 North America
- 184.108.40.206 United States (By Product, Application, and End User)
- 220.127.116.11 Canada (By Product, Application, and End User)
- 18.104.22.168 Mexico (By Product, Application, and End User)
- 5.4.2 Europe
- 22.214.171.124 Germany (By Product, Application, and End User)
- 126.96.36.199 United Kingdom (By Product, Application, and End User)
- 188.8.131.52 France (By Product, Application, and End User)
- 184.108.40.206 Italy (By Product, Application, and End User)
- 220.127.116.11 Spain (By Product, Application, and End User)
- 18.104.22.168 Rest of Europe (By Product, Application, and End User)
- 5.4.3 Asia-Pacific
- 22.214.171.124 China (By Product, Application, and End User)
- 126.96.36.199 Japan (By Product, Application, and End User)
- 188.8.131.52 India (By Product, Application, and End User)
- 184.108.40.206 Australia (By Product, Application, and End User)
- 220.127.116.11 South Korea (By Product, Application, and End User)
- 18.104.22.168 Rest of Asia-Pacific (By Product, Application, and End User)
- 5.4.4 Middle-East and Africa
- 22.214.171.124 GCC (By Product, Application, and End User)
- 126.96.36.199 South Africa (By Product, Application, and End User)
- 188.8.131.52 Rest of Middle-East and Africa (By Product, Application, and End User)
- 5.4.5 South America
- 184.108.40.206 Brazil (By Product, Application, and End User)
- 220.127.116.11 Argentina (By Product, Application, and End User)
- 18.104.22.168 Rest of South America (By Product, Application, and End User)
6 COMPETITIVE LANDSCAPE
- 6.1 Company Profiles
- 6.1.1 Becton, Dickinson and Company
- 6.1.2 Cardinal Health
- 6.1.3 Terumo Corporation
- 6.1.4 FRESENIUS KABI
- 6.1.5 Haemonetics Corporation
- 6.1.6 Henry Schein Inc.
- 6.1.7 McKesson Corporation
- 6.1.8 Medline Industries Inc.
- 6.1.9 PreQ Systems
- 6.1.10 Qiagen
- 6.1.11 Grifols
- 6.1.12 Smiths Medical
- 6.1.13 Quest Diagnostics
- 6.1.14 Nipro Medical Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS